GSK invest €8m at Dungarvan facility

GSK have invested €8 million in a new biomass energy unit at its manufacturing site in Dungarvan, Waterford to reduce the company’s carbon output. The purpose-built biomass energy facility is expected to reduce the site’s carbon emissions by up to 33%. The facility uses locally sourced woodchips instead of oil to create a carbon neutral fuel source for the site. This investment is part of GSK’s global sustainability strategy which aims to make the company carbon neutral by 2050.